7Mody FV, Singh BN, Mohiuddin IH, et al. Trimetazidine-induced enhancement of myocardial Sluco-utilization in nomud an d ischemic myocardial tissue: ane valuation by positron emission tomography[J]. Am J Cardiol, 1998, 82(5A) : 42k - 49k.
8Lopaschuk CD.Treating ischemic heart disease by pharmacologitally improving cardiac energy metabolism [J].Am J Cardiol, 1998, 82 (5A) : 14k-17k.
9[1]Kimmelstiel C,Badar J,Covic L,et al.Pharmacodynamics and pharmacokineties of the platelet GP Ⅱb/Ⅲa inhibitor tirofiban in patients undergoing percutaneous coronary intervention:imp-lications for adjustment of tirofiban and clop idogrel dosage[J].Thromb Res,2005,116(1):55-66.
10[2]Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction:executive summary and recommendations.A report of the American College of Cardiology/American Hear Association task force on practice guiddines(committee on the management of patients with unstable angina)[J].Circulation,2000,102(10):1193-1199.
